GlassScriptPhysician profile
Nicholas Mansuetta
NPI 1013069897
$1,835.45
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $996 · 2020: $339 · 2021: $462 · 2022: $38.51.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $795.34 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $248.27 | 2020 | |
| Skeletal Dynamics INC | $102.06 | 2019 | |
| Upsher-Smith Laboratories LLC | $82.05 | 2021 | |
| Rsw Medical Company, INC. | $66.48 | 2019 | |
| Endo Pharmaceuticals INC. | $57.87 | 2019-2020 | |
| Innovation Technologies INC | $55.72 | 2021 | |
| Amgen INC. | $49.95 | 2021 | |
| Dexcom, INC. | $49.61 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $47.81 | 2021 | |
| Genentech USA, INC. | $37.47 | 2020-2021 | |
| Abbvie INC. | $36.29 | 2021 | |
| Novo Nordisk INC | $25.64 | 2021 | |
| Merck Sharp & Dohme LLC | $24.53 | 2020 | |
| Lilly USA, LLC | $23.55 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $23.13 | 2021 | |
| Optinose US, INC. | $21.23 | 2022 | |
| Genzyme Corporation | $19.25 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $15.68 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.28 | 2021 | |
| Glaxosmithkline, LLC. | $14.04 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $12.53 | 2021 | |
| Conetic Solutions, INC. | $11.67 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Mansuetta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.